Inactivated Influenza Vaccine Market Anticipated To Witness Robust Growth, Surpassing 9.99 Billion By 2029

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Current Inactivated Influenza Vaccine Market Size and Its Estimated Growth Rate?
The market for inactivated influenza vaccines has seen substantial growth over the past few years. The market is projected to expand from $6.62 billion in 2024 to $7.21 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 8.9%. This growth in the past time frame can be traced back to factors such as increased occurrences of seasonal influenza, governmental drives for vaccination, growing aged populace, heightened public health consciousness and advancements in healare infrastructure.

The market size for the inactivated influenza vaccine is projected to significantly expand in the upcoming years, reaching an estimated value of $9.99 billion in 2029 with a compound annual growth rate (CAGR) of 8.5%. The escalation predicted during this period is largely due to factors such as the heightened need for quadrivalent vaccines, burgeoning immunization initiatives, an increased emphasis on pandemic readiness, advancements in vaccine manufacturing technology, and improved access to vaccines worldwide. Key trends foreseen for the forecast period encompass a shift towards cell-based vaccine manufacturing, escalating adoption of adjuvanted formulations, merging of influenza vaccines with COVID-19 boosters, surging demand in developing markets, and individualized vaccine development approaches.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24251&type=smp

How Are Emerging Segments Shaping the Inactivated Influenza Vaccine Market Landscape?
The inactivated influenza vaccine market covered in this report is segmented -

1) By Type Of Vaccine: Trivalent Inactivated Influenza Vaccine (TIIV), Quadrivalent Inactivated Influenza Vaccine (QIIV)
2) By Application: Children, Adolescence, Adults, Elderly
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Public Health Clinics
4) By End-User: Healare Providers, Individuals, Government Organizations, Pharmaceutical Companies

Subsegments:
1) Trivalent Inactivated Influenza Vaccine (TIIV): Egg-based Trivalent Inactivated Influenza Vaccine, Cell-based Trivalent Inactivated Influenza Vaccine, Adjuvanted Trivalent Inactivated Influenza Vaccine, High-dose Trivalent Inactivated Influenza Vaccine
2) Quadrivalent Inactivated Influenza Vaccine (QIIV): Egg-based Quadrivalent Inactivated Influenza Vaccine, Cell-based Quadrivalent Inactivated Influenza Vaccine, Adjuvanted Quadrivalent Inactivated Influenza Vaccine, Recombinant Quadrivalent Inactivated Influenza Vaccine, Pediatric Quadrivalent Inactivated Influenza Vaccine

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24251&type=smp

Which Growth Factors Are Influencing Inactivated Influenza Vaccine Market Expansion?
The growth of the inactivated influenza vaccine market is anticipated to be fuelled by increasing government vaccination programs. This growth is heightened by the health consciousness of the public, resulting in a surge of demand for immunization services and inspiring governments to improve accessibility and initiation of vaccines. By providing the inactivated influenza vaccines at a low cost or free of charge to those at higher risk, governmental vaccination programs allow for fair vaccination coverage and lessen the impact of seasonal influenza. For example, in December 2023, the UK's National Health Service launched an NHS vaccine scheme to meet its immunization targets. This scheme incorporates plans for locally-based vaccination services, mainly focusing on undeserved and marginalized communities. As such, the escalation of government vaccination programs contributes significantly to the expansion of the inactivated influenza vaccine market.

Who Are the Dominant Players Across Different Inactivated Influenza Vaccine Market Segments?
Major companies operating in the inactivated influenza vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis International, GlaxoSmithKline plc, Viatris Inc., CSL, Zydus Lifesciences Limited, Sinovac Biotech Ltd., Bharat Biotech International Limited, Dalian Aleph Biomedical Co. Ltd., Hualan Biological Bacterin Co. Ltd, Changchun Biological, Jiangsu gdk Biotechnology Co., Ltd., KM Biologics, JoinHub Pharma, Pharmika India Private Limited.

What Trends Are Driving Growth in The Inactivated Influenza Vaccine Market?
Leading firms in the inactivated influenza vaccine market are channelizing their efforts towards the creation of quadrivalent inactivated influenza vaccines. These vaccines provide enhanced protection against four different strains of the influenza virus. For example, Zydus Lifesciences, a pharmaceutical company based out of India, introduced a quadrivalent inactivated influenza vaccine named VaxiFlu-4, in February 2025. This vaccine is aimed at providing seasonal protection against four new virus strains and is designed to cover both influenza A and B strains. This broad spectrum of coverage lowers the likelihood of vaccine mismatch. The vaccine is engineered to mitigate seasonal flu outbreaks through an improved immune response that aligns with regional epidemiological patterns.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/inactivated-influenza-vaccine-global-market-report

Which Geographic Regions Are Expected to Dominate the Inactivated Influenza Vaccine Market in the Coming Years?
North America was the largest region in the inactivated influenza vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inactivated influenza vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Inactivated Influenza Vaccine Market?
2. What is the CAGR expected in the Inactivated Influenza Vaccine Market?
3. What Are the Key Innovations Transforming the Inactivated Influenza Vaccine Industry?
4. Which Region Is Leading the Inactivated Influenza Vaccine Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.